Evidence used
- No CISA KEV confirmation is currently recorded.
- A structured source references public exploit or proof-of-concept material.
- EPSS is 0.15% for the current model date.
BlackTreeCVE IntelligenceSourceCodester · Drug Recommendation System
Medium technical severity with public exploit material referenced by a structured source; prioritise exposed affected systems while verifying vendor guidance.
Medium technical severity with public exploit material referenced by a structured source; prioritise exposed affected systems while verifying vendor guidance.
Fix not verifiedA weakness has been identified in SourceCodester Drug Recommendation System 1.0. This affects an unknown function of the file Admin/add_user.php of the component Password Handler. Executing a manipulation of the argument Password can lead to missing encryption of sensitive data. It is possible to launch the attack remotely. The exploit has been made available to the public and could be used for attacks.
A weakness has been identified in SourceCodester Drug Recommendation System 1.0. This affects an unknown function of the file Admin/add_user.php of the component Password Handler. Executing a manipulation of the argument Password can lead to missing encryption of sensitive data. It is possible to launch the attack remotely. The exploit has been made available to the public and could be used for attacks.
The product does not encrypt sensitive or critical information before storage or transmission.
An attacker operating through a network path may attempt exploitation with elevated privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
A weakness has been identified in SourceCodester Drug Recommendation System 1.0. This affects an unknown function of the file Admin/add_user.php of the component Password Handler. Executing a manipulation of the argument Password can lead to missing encryption of sensitive data. It is possible to launch the attack remotely. The exploit has been made available to the public and could be used for attacks.
The product does not encrypt sensitive or critical information before storage or transmission.
An attacker operating through a network path may attempt exploitation with elevated privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
CISA Vulnrichment records proof-of-concept exploitation in its SSVC data. BlackTree has not independently executed or validated exploit material.
CWE-311: Missing Encryption of Sensitive Data. The product does not encrypt sensitive or critical information before storage or transmission.
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:PCommon Vulnerability Scoring System 4.0: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 5 Oct 2026 · Last source change 5 Oct 2026, 14:42 UTC · CWE-311 · Missing Encryption of Sensitive Data
Core structured fields are present and their contributing authorities are shown above.